“IS IT TIME FOR PCSK9 INHIBITOR TO BE USED AS STANDARD OF CARE FOR CARDIAC PATIENTS? – AN ASIAN PERSPECTIVE” BY DR JEREMY CHOW

Share the Post:

Professional Heart & Vascular Services

Search Our Tag Cloud

Patients & Public (27)

Resources (14)

Blog (4)

ASM (3)

CME Webinar (2)

Events (1)

GP Talks (3)

Health Care Providers (8)

Browse Our Categories

SIGN UP FOR OUR EMAIL NEWSLETTER

Stay informed by signing up for the Morning Briefing and other emails:

Related Articles

Patients & Public

BUBBLE CONTRAST TRANSCRANIAL DOPPLER TCD, TEST TO IDENTIFY PATENT FORAMEN OVALE TO REDUCE RECURRENCE OF STROKE

Patients & Public

WHAT EVERY WOMEN NEEDS TO KNOW ABOUT HEART DISEASE

GP Talks, Health Care Providers, Resources

TREATING CHOLESTEROL IN ASIAN PATIENTS: BALANCING THE RISK AND BENEFITS

Events, Patients & Public

HEART TO HEART TALK 2023

Resources, Patients & Public

WHAT IS TRICVALVE?

Health Care Providers, Resources

ASM AUGUST 2022

Patients & Public

LEAKING MITRAL HEART VALVE

Patients & Public

UNDERSTANDING THE RELATIONSHIP BETWEEN PFO AND STROKE